Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Allovir, Inc. | d932810dex211.htm |
| EX-10.12 - EX-10.12 - Allovir, Inc. | d932810dex1012.htm |
| EX-10.11 - EX-10.11 - Allovir, Inc. | d932810dex1011.htm |
| EX-10.10 - EX-10.10 - Allovir, Inc. | d932810dex1010.htm |
| EX-10.9 - EX-10.9 - Allovir, Inc. | d932810dex109.htm |
| EX-10.6 - EX-10.6 - Allovir, Inc. | d932810dex106.htm |
| EX-10.5 - EX-10.5 - Allovir, Inc. | d932810dex105.htm |
| EX-10.4 - EX-10.4 - Allovir, Inc. | d932810dex104.htm |
| EX-10.1 - EX-10.1 - Allovir, Inc. | d932810dex101.htm |
| EX-4.2 - EX-4.2 - Allovir, Inc. | d932810dex42.htm |
| EX-3.4 - EX-3.4 - Allovir, Inc. | d932810dex34.htm |
| EX-3.1 - EX-3.1 - Allovir, Inc. | d932810dex31.htm |
| S-1 - S-1 - Allovir, Inc. | d932810ds1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated June 3, 2020, relating to the financial statements of AlloVir, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
July 6, 2020